| 0.66 Data as of May 22 | -0.015 / -2.22%Today’s Change | 0.43 Today|||52-Week Range 0.99 | +17.86% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Provectus Pharmaceuticals Inc have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50. The median estimate represents a +430.30% increase from the last price of 0.66.

There are no recommendations available.

Move your mouse over a quarter or year to see how estimates have changed over time.




